The extensive toolbox has a lot to offer

The fact that most type 2 diabetics today aim for an HbA_1c value of <7% is partly due to the results of the UKPDS. This landmark study showed that the risk of microvascular complications could be significantly reduced as a result. Another milestone was the launch of GLP-1-RA and SGLT-2-i – state-of-the-art drugs that not only have glucose-lowering effects, but also have independent cardio- and nephroprotective effects.